Crohnz · Your decision, your values

Surgery now, or keep trying medication?

When limited Crohn's at the end of the small bowel (the ileocecal area) isn't settling on medication, you may have a real choice: a keyhole operation to remove the inflamed segment, or stepping up to a biologic like infliximab. A landmark trial, LIR!C, put these head to head and followed patients for years.12 Its finding: neither is simply “better.” Quality of life ends up about the same, and the right fit depends on what matters to you.

This choice applies to a specific situation. LIR!C studied Crohn's that mainly causes inflammation (not a tight narrowing/stricture) in a short segment (about 40 cm or less) at the ileocecal junction, when conventional treatment hasn't worked.1 If your disease is different, your options differ. Your team can tell you whether this fits you. This tool doesn't choose for you.

1 · Tell us what matters most to you

Tap any that matter, the comparison below highlights those rows on both options. There are no wrong answers.

2 · See the two options side by side

Step up to a biologic

Infusions / injections · keep your whole bowel
“They removed the inflamed part in one keyhole operation. Within about a week I was home, and for the first time in years I was off steroids.”
“Every few weeks I get an infusion. It kept me out of the operating room and let me keep my whole bowel.”
⚡
Often a quick turnaroundThe inflamed segment is removed in one operation; many people feel better soon after and can come off steroids. Expect a dip for the first week or two while you recover.1
💉
Works over weeksThe biologic is started as infusions or injections and takes effect over weeks, with no operation and no recovery period.1
🔬
One keyhole operationA laparoscopic (keyhole) operation removes the inflamed ileocecal segment, usually a few days in hospital.1
🏥
Ongoing treatmentRegular infusions or injections that continue long-term, with blood tests and monitoring along the way.1
💊
Many come off drugs afterLong-term, most did not need more biologic: about 74% needed no further biologic, and 42% needed no further Crohn's treatment at all.2
🔁
You stay on the biologicYou keep taking the drug to hold the disease down, with its ongoing schedule, monitoring, and effects on the immune system.2
🌤️
Quality of life is goodAt one year, quality of life after surgery was about the same as with the drug.1
🌤️
Quality of life is goodAt one year, quality of life on the biologic was about the same as after surgery.1
📈
Durable for manyFollowed for 5+ years, most did well and none needed a second resection. Some later needed medication, and Crohn's is watched for at the join.2
⏳
About half later had surgeryAround 48% of people who started on the biologic ended up having the operation anyway, a median of about 17 months later.2
🩹
Operation & recoverySurgery carries the usual risks of an operation and a recovery period; in this planned, keyhole setting serious complications are uncommon.1
🛡️
Drug side effectsBiologics can raise the risk of infection and, rarely, cause reactions; they need ongoing monitoring.1
🔎
Can return at the joinCrohn's can come back where the bowel was rejoined. This is watched for with check-ups and treated, often with medication, if it does.2
🔄
Can escalate or switchIf the drug stops working, the dose can change or you can switch drugs, or move to surgery.2
💷
More cost-effectiveOver the first year, surgery cost less overall and was found more cost-effective than the drug.3
💳
Ongoing cost & visitsThe biologic has continuing costs and regular infusion or injection visits.3

How it can unfold over time ⏳

🏥 First weeks
📅 First months
🗓️ First year
⏳ Years later
One operation, ~1 week in hospital
Off drugs, back to normal life
Quality of life like the drug
74% need no further biologic
Biologic
Start infusions / injections
Regular infusions + monitoring
Quality of life like surgery
~48% eventually have surgery

3 · Questions to take to your team

A starting list to make the conversation easier.

Open the question list ＋
  • Is my Crohn's the limited, mainly-inflammatory ileocecal type this choice applies to?
  • If I have surgery, would it be keyhole, and how long is recovery likely to be for me?
  • If I start the biologic, how will we know it's working, and when would we reconsider surgery?
  • How likely am I to need the other option later?
  • What are the main risks and side effects of each for me specifically?
  • Would surgery let me come off medication?
  • What follow-up or monitoring would I need after each?
  • Could I speak with someone who has chosen each path?

What this is based on

Built on the LIR!C randomised trial and its long-term follow-up, the strongest head-to-head evidence comparing surgery with infliximab for limited ileocecal Crohn's.12

  1. 1. Ponsioen CY, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial (LIR!C). Lancet Gastroenterol Hepatol. 2017. PMID: 28838644
  2. 2. Stevens TW, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413
  3. 3. de Groof EJ, et al. Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial. Gut. 2019. PMID: 31233395

Nothing selected yet. There are no wrong answers. Bring what matters to you into the conversation. Information alone doesn't settle the decision, so talk it through with your team.

An independent educational project of Holubar Lab. Views are the author's own, not those of Cleveland Clinic. This is not a recommendation and not a substitute for advice from your care team. © Stefan D. Holubar, all rights reserved.